Skip to content
OpenCapital
Get started

Aspire Biopharma Holdings, Inc. ASBP Q3 2025 earnings

Reported November 14, 2025 · Before market open

Revenue$1.9KDiluted EPS-$1.60

Next report

Date not yet announced

Versus estimates

Revenue

Q1 2026$28.4KQ4 2025$4.3K
Q3 2025$1.9K

Diluted EPS

Q1 2026-$20.57Q4 2025-$1.33
Q3 2025-$1.60
Q2 2025-$0.04Q1 2025-$0.42Q4 2024-$0.27

Ask the moment Aspire Biopharma Holdings, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Aspire Biopharma Holdings, Inc. report Q3 2025 earnings?
Aspire Biopharma Holdings, Inc. (ASBP) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Aspire Biopharma Holdings, Inc.'s Q3 2025 revenue and EPS?
Aspire Biopharma Holdings, Inc. reported revenue of $1.9K and diluted EPS of $-1.60 for Q3 2025.
How did Aspire Biopharma Holdings, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 9153.9% from $-0.02.
Where can I find Aspire Biopharma Holdings, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-022580) and the 10-Q/A periodic report (0001493152-25-023619) directly on SEC EDGAR. The filing index links above go to sec.gov.